首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Comparison of molecular analysis and touch imprint cytology for the intraoperative evaluation of sentinel lymph nodes in primary breast cancer: Results of the China Breast Cancer Clinical Study Group (CBCSG) 001c trial
【24h】

Comparison of molecular analysis and touch imprint cytology for the intraoperative evaluation of sentinel lymph nodes in primary breast cancer: Results of the China Breast Cancer Clinical Study Group (CBCSG) 001c trial

机译:分子分析和触摸印迹细胞学在术中评估原发性乳腺癌前哨淋巴结的比较:中国乳腺癌临床研究组(CBCSG)001c试验的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background: To validate the clinical value of the One-Step Nucleic Acid Amplification (OSNA) Breast Cancer System for the intraoperative detection of sentinel lymph node (SLN) metastases in early-stage breast cancer patients in a Chinese population, a prospective, multicenter trial, the China Breast Cancer Clinical Study Group (CBCSG)-001c trial, was conducted. The present study focused on the prospective comparison of the performance between OSNA and touch imprint cytology (TIC). Methods: The retrieved SLNs were divided into sections. Alternate slices from the tissue blocks were subjected either to OSNA analysis or to postoperative histopathology evaluation through serial sectioning. TIC was performed on every sample surface of each tissue block and was used by the surgeon to determine whether to perform an immediate ALND. Results: A total of 552 patients qualified for the analysis. The sensitivity, specificity, and overall accuracy of OSNA were 87.8%, 89.6%, and 88.4%, respectively, on a per-patient basis compared with those of TIC, which were 81.3%, 96.9%, and 92.0%, respectively. OSNA detected more micrometastasis-involved nodes than TIC (52.8% vs. 25.0%; p = 0.029) on a per-node basis. Tissue allocation bias (TAB) was the main cause of discordant results. The performance of TIC varied significantly among the institutes, while the performance of OSNA was steady. Conclusions: Both OSNA and TIC can serve as qualified intraoperative assessments of SLNs. For institutes lacking the support of experienced cytopathologists, OSNA can be the first choice for the intraoperative assessment. In addition, OSNA can be applied as a complement to histopathology assessment. However, the results of the present study do not support the routine application of OSNA in the entire SLNs in place of pathology with serial sectioning.
机译:背景:一项前瞻性,多中心试验,旨在验证一步法核酸扩增(OSNA)乳腺癌系统在术中检测中国人群早期乳腺癌患者前哨淋巴结(SLN)转移的临床价值。进行了中国乳腺癌临床研究小组(CBCSG)-001c试验。本研究侧重于OSNA和触摸印迹细胞学(TIC)之间的性能的前瞻性比较。方法:将检索到的SLN分为多个部分。通过连续切片对来自组织块的备用切片进行OSNA分析或术后组织病理学评估。 TIC在每个组织块的每个样本表面上进行,并由外科医生用来确定是否立即进行ALND。结果:共有552名患者符合分析条件。与TIC相比,OSNA的敏感性,特异性和整体准确性分别为每位患者87.8%,89.6%和88.4%,而TIC分别为81.3%,96.9%和92.0%。在每个节点的基础上,OSNA比TIC检测到更多涉及微转移的节点(52.8%vs. 25.0%; p = 0.029)。组织分配偏差(TAB)是导致结果不一致的主要原因。各机构间TIC的表现差异很大,而OSNA的表现则稳定。结论:OSNA和TIC均可作为SLN的合格术中评估。对于缺乏经验丰富的细胞病理学家支持的研究所,OSNA可以作为术中评估的首选。此外,OSNA可以作为组织病理学评估的补充。然而,本研究的结果不支持OSNA在整个SLN中的常规应用,而不是采用连续切片的病理学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号